Nanotech used in search for cancer drugs

Researchers at Wake Forest University are developing a nanotech process which could potentially speed the search for new anti-cancer drugs. The "Lab-on-Bead" process involves using tiny plastic beads, each carrying a different chemical, to identify which chemicals display cancer-fighting properties. Technologies currently in use only allow researchers to screen several hundred thousand drug candidates per day, while this technique is expected to allow researchers the ability to screen more than a billion possible drug candidates in that time.

Wake Forest is conducting the project in partnership with the University of Waterloo in Ontario, Canada, with funding from the North Carolina Biotechnology Center.

- read The Business Journal for more

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.